Published in J Immunol on November 15, 1996
Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus. EMBO J (1998) 5.15
The ubiquitin-like protein Smt3p is activated for conjugation to other proteins by an Aos1p/Uba2p heterodimer. EMBO J (1997) 4.80
Apg7p/Cvt2p: A novel protein-activating enzyme essential for autophagy. Mol Biol Cell (1999) 4.68
Modification of yeast Cdc53p by the ubiquitin-related protein rub1p affects function of the SCFCdc4 complex. Genes Dev (1998) 3.84
SUMO-1 modification and its role in targeting the Ran GTPase-activating protein, RanGAP1, to the nuclear pore complex. J Cell Biol (1998) 3.65
The SCF(COI1) ubiquitin-ligase complexes are required for jasmonate response in Arabidopsis. Plant Cell (2002) 3.34
Fibroblast biology. Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis. Arthritis Res (2000) 3.27
Mechanisms, regulation and consequences of protein SUMOylation. Biochem J (2010) 3.22
Cell cycle-regulated attachment of the ubiquitin-related protein SUMO to the yeast septins. J Cell Biol (1999) 3.03
Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1. J Cell Biol (1997) 2.98
Sequestration and inhibition of Daxx-mediated transcriptional repression by PML. Mol Cell Biol (2000) 2.59
Molecular characterization of the SUMO-1 modification of RanGAP1 and its role in nuclear envelope association. J Cell Biol (1998) 2.29
A universal strategy for proteomic studies of SUMO and other ubiquitin-like modifiers. Mol Cell Proteomics (2004) 2.21
The ubiquitin-like proteins SMT3 and SUMO-1 are conjugated by the UBC9 E2 enzyme. Proc Natl Acad Sci U S A (1998) 2.05
Characterization of a fission yeast SUMO-1 homologue, pmt3p, required for multiple nuclear events, including the control of telomere length and chromosome segregation. Mol Cell Biol (1999) 1.97
Role of desumoylation in the development of prostate cancer. Neoplasia (2006) 1.90
SUMO1-dependent modulation of SERCA2a in heart failure. Nature (2011) 1.89
Scythe: a novel reaper-binding apoptotic regulator. EMBO J (1998) 1.77
ND10 protein PML is recruited to herpes simplex virus type 1 prereplicative sites and replication compartments in the presence of viral DNA polymerase. J Virol (1998) 1.75
TNF-induced signaling in apoptosis. J Clin Immunol (1999) 1.71
Tumour necrosis factors receptor associated signalling molecules and their role in activation of apoptosis, JNK and NF-kappaB. Ann Rheum Dis (2000) 1.48
SUMO-1 conjugation to topoisomerase I: A possible repair response to topoisomerase-mediated DNA damage. Proc Natl Acad Sci U S A (2000) 1.47
A MHC-encoded ubiquitin-like protein (FAT10) binds noncovalently to the spindle assembly checkpoint protein MAD2. Proc Natl Acad Sci U S A (1999) 1.44
Retracted Detection of ubiquityl-calmodulin conjugates with a novel high-molecular weight ubiquitylprotein-isopeptidase in rabbit tissues. Eur J Med Res (2010) 1.39
Covalent modification of the transcriptional repressor tramtrack by the ubiquitin-related protein Smt3 in Drosophila flies. Mol Cell Biol (2000) 1.36
Receptor-mediated choreography of life and death. J Clin Immunol (2003) 1.33
Human pathogens and the host cell SUMOylation system. J Virol (2011) 1.31
PIC-1/SUMO-1-modified PML-retinoic acid receptor alpha mediates arsenic trioxide-induced apoptosis in acute promyelocytic leukemia. Mol Cell Biol (1999) 1.25
FIST/HIPK3: a Fas/FADD-interacting serine/threonine kinase that induces FADD phosphorylation and inhibits fas-mediated Jun NH(2)-terminal kinase activation. J Exp Med (2000) 1.24
Oxidized LDL activates fas-mediated endothelial cell apoptosis. J Clin Invest (1998) 1.23
Modification of nuclear PML protein by SUMO-1 regulates Fas-induced apoptosis in rheumatoid arthritis synovial fibroblasts. Proc Natl Acad Sci U S A (2007) 1.22
FLICE-inhibitory protein is a key regulator of germinal center B cell apoptosis. J Exp Med (2001) 1.20
Poly-small ubiquitin-like modifier (PolySUMO)-binding proteins identified through a string search. J Biol Chem (2012) 1.19
NUB1 suppresses the formation of Lewy body-like inclusions by proteasomal degradation of synphilin-1. Am J Pathol (2006) 1.14
A novel gene coding for a Fas apoptosis inhibitory molecule (FAIM) isolated from inducibly Fas-resistant B lymphocytes. J Exp Med (1999) 1.07
Regulation of double-strand break-induced mammalian homologous recombination by UBL1, a RAD51-interacting protein. Nucleic Acids Res (2000) 1.06
Evolution of a signalling system that incorporates both redundancy and diversity: Arabidopsis SUMOylation. Biochem J (2006) 1.05
Neuronal SUMOylation: mechanisms, physiology, and roles in neuronal dysfunction. Physiol Rev (2014) 1.02
Ubc9 regulates mitosis and cell survival during zebrafish development. Mol Biol Cell (2006) 1.00
The Fas counterattack: a molecular mechanism of tumor immune privilege. Mol Med (1997) 0.99
SUMO and SUMOylation in plants. Mol Cells (2011) 0.99
Comparison of the SUMO1 and ubiquitin conjugation pathways during the inhibition of proteasome activity with evidence of SUMO1 recycling. Biochem J (2005) 0.95
Association of FHIT (fragile histidine triad), a candidate tumour suppressor gene, with the ubiquitin-conjugating enzyme hUBC9. Biochem J (2000) 0.90
SUMO-1 represses apoptosis signal-regulating kinase 1 activation through physical interaction and not through covalent modification. EMBO Rep (2005) 0.89
TRUSS, a novel tumor necrosis factor receptor 1 scaffolding protein that mediates activation of the transcription factor NF-kappaB. Mol Cell Biol (2003) 0.89
Role of Ser129 phosphorylation of α-synuclein in melanoma cells. J Cell Sci (2012) 0.87
Influence of ND10 components on epigenetic determinants of early KSHV latency establishment. PLoS Pathog (2014) 0.86
Sumoylation at the host-pathogen interface. Biomolecules (2012) 0.86
Emerging roles of SUMO modification in arthritis. Gene (2010) 0.84
A mechanistic view of the role of E3 in sumoylation. PLoS Comput Biol (2010) 0.83
Identifications of SUMO-1 cDNA and its expression patterns in Pacific white shrimp Litopeanaeus vannamei. Int J Biol Sci (2009) 0.83
In vivo analysis of protein sumoylation induced by a viral protein: Detection of HCMV pp71-induced Daxx sumoylation. Methods (2011) 0.83
Identification of SUMO-interacting proteins by yeast two-hybrid analysis. Methods Mol Biol (2009) 0.82
Cytoplasmic relocation of Daxx induced by Ro52 and FLASH. Histochem Cell Biol (2010) 0.81
Identification of a non-covalent ternary complex formed by PIAS1, SUMO1, and UBC9 proteins involved in transcriptional regulation. J Biol Chem (2013) 0.81
Cloning and identification of NS5ATP2 gene and its spliced variant transactivated by hepatitis C virus non-structural protein 5A. World J Gastroenterol (2004) 0.80
Tumor strengths and frailties: Cancer SUMmOns Otto's metabolism. Nat Med (2012) 0.79
SUMOylation protects against IL-1β-induced apoptosis in INS-1 832/13 cells and human islets. Am J Physiol Endocrinol Metab (2014) 0.79
mRNA expression analysis of the SUMO pathway genes in the adult mouse retina. Biol Open (2015) 0.78
Lack of activation induced cell death in human T blasts despite CD95L up-regulation: protection from apoptosis by MEK signalling. Immunology (1999) 0.76
SUMO enters the ring. J Cell Biol (2015) 0.75
Allosteric activation of SENP1 by SUMO1 β-grasp domain involves a dock-and-coalesce mechanism. Elife (2016) 0.75
Sumoylation-independent activation of Calcineurin-NFAT-signaling via SUMO2 mediates cardiomyocyte hypertrophy. Sci Rep (2016) 0.75
Pharmacogenomics knowledge for personalized medicine. Clin Pharmacol Ther (2012) 6.92
NELF, a multisubunit complex containing RD, cooperates with DSIF to repress RNA polymerase II elongation. Cell (1999) 6.34
PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. J Cell Biol (1999) 5.83
Evidence that Spt4, Spt5, and Spt6 control transcription elongation by RNA polymerase II in Saccharomyces cerevisiae. Genes Dev (1998) 5.16
Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation (2000) 4.81
Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest (1999) 4.66
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing. Clin Pharmacol Ther (2011) 4.42
Ubiquitin-like proteins: new wines in new bottles. Gene (2000) 3.46
Essential involvement of interleukin-8 (IL-8) in acute inflammation. J Leukoc Biol (1994) 3.35
p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice. J Clin Invest (2001) 3.02
TRIPTYCHON and CAPRICE mediate lateral inhibition during trichome and root hair patterning in Arabidopsis. EMBO J (2002) 2.92
The clinical pharmacogenomics implementation consortium: CPIC guideline for SLCO1B1 and simvastatin-induced myopathy. Clin Pharmacol Ther (2012) 2.90
A highly purified RNA polymerase II elongation control system. J Biol Chem (2001) 2.84
Snurportin1, an m3G-cap-specific nuclear import receptor with a novel domain structure. EMBO J (1998) 2.71
Characterization of NEDD8, a developmentally down-regulated ubiquitin-like protein. J Biol Chem (1997) 2.64
Identification of three major sentrinization sites in PML. J Biol Chem (1998) 2.54
Correlates of partner violence among female street-based sex workers: substance abuse, history of childhood abuse, and HIV risks. AIDS Patient Care STDS (2001) 2.47
Type I phosphatidylinositol-4-phosphate 5-kinases. Cloning of the third isoform and deletion/substitution analysis of members of this novel lipid kinase family. J Biol Chem (1998) 2.42
Differential regulation of sentrinized proteins by a novel sentrin-specific protease. J Biol Chem (2000) 2.34
Synergistic interaction of p185c-neu and the EGF receptor leads to transformation of rodent fibroblasts. Cell (1989) 2.30
Characterization of the MexC-MexD-OprJ multidrug efflux system in DeltamexA-mexB-oprM mutants of Pseudomonas aeruginosa. Antimicrob Agents Chemother (1998) 2.29
RPT2. A signal transducer of the phototropic response in Arabidopsis. Plant Cell (2000) 2.26
Structure and function of the human transcription elongation factor DSIF. J Biol Chem (1999) 2.19
Sequence and analysis of chromosome 3 of the plant Arabidopsis thaliana. Nature (2000) 2.17
Identification of the gene loci that predispose to rheumatoid arthritis. Int Immunol (1998) 2.16
Sequence and analysis of chromosome 5 of the plant Arabidopsis thaliana. Nature (2000) 2.16
Covalent modification of PML by the sentrin family of ubiquitin-like proteins. J Biol Chem (1998) 2.15
Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine. Am J Pathol (2001) 2.15
Identification of the activating and conjugating enzymes of the NEDD8 conjugation pathway. J Biol Chem (1999) 2.15
Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators. Circulation (2000) 2.15
Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation (2001) 2.03
Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis. Clin Cancer Res (2000) 2.02
A tale of two diseases: atherosclerosis and rheumatoid arthritis. Circulation (1999) 1.93
A regulator of transcriptional elongation controls vertebrate neuronal development. Nature (2000) 1.87
Preferential interaction of sentrin with a ubiquitin-conjugating enzyme, Ubc9. J Biol Chem (1997) 1.86
A U-shaped association between home systolic blood pressure and four-year mortality in community-dwelling older men. J Am Geriatr Soc (1999) 1.86
Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group. J Hypertens (1998) 1.83
Preferential modification of nuclear proteins by a novel ubiquitin-like molecule. J Biol Chem (1997) 1.80
Relative abundance of organochlorine pesticides and polychlorinated biphenyls in adipose tissue and serum of women in Long Island, New York. Cancer Epidemiol Biomarkers Prev (1998) 1.77
Structural characterization of the TAP molecule: a phosphatidylinositol-linked glycoprotein distinct from the T cell receptor/T3 complex and Thy-1. Cell (1986) 1.77
Synthesis of a muscarinic receptor antagonist via a diastereoselective Michael reaction, selective deoxyfluorination and aromatic metal-halogen exchange reaction. J Org Chem (2001) 1.75
Proteinchip(R) surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures. Prostate Cancer Prostatic Dis (1999) 1.73
Gene transfer of RANTES elicits autoimmune renal injury in MRL-Fas(1pr) mice. Kidney Int (1998) 1.71
Chinese trial on isolated systolic hypertension in the elderly. Systolic Hypertension in China (Syst-China) Collaborative Group. Arch Intern Med (2000) 1.69
Reduction in risk of mortality from colorectal cancer by fecal occult blood screening with immunochemical hemagglutination test. A case-control study. Int J Cancer (1995) 1.67
Bilateral intracranial vertebral artery disease in the New England Medical Center, Posterior Circulation Registry. Arch Neurol (1999) 1.67
Reconsidering recent myocardial infarction as a contraindication for IV stroke thrombolysis. Neurology (2011) 1.66
Stimulation of RNA polymerase II elongation by hepatitis delta antigen. Science (2001) 1.66
IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice. J Immunol (1998) 1.65
Identification of NEDD8-conjugation site in human cullin-2. Biochem Biophys Res Commun (1999) 1.63
Primary intraosseous carcinoma: review of the literature and diagnostic criteria. J Oral Maxillofac Surg (1994) 1.60
Multi-institutional study on the teratogenicity and fetal toxicity of antiepileptic drugs: a report of a collaborative study group in Japan. Epilepsia (1980) 1.58
Possible identity of diffuse sclerosing osteomyelitis and chronic recurrent multifocal osteomyelitis. One entity or two. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1995) 1.57
Interplay between positive and negative elongation factors: drawing a new view of DRB. Genes Cells (1998) 1.53
Regulation of microphthalmia-associated transcription factor MITF protein levels by association with the ubiquitin-conjugating enzyme hUBC9. Exp Cell Res (2000) 1.53
ADAMTS-1: a metalloproteinase-disintegrin essential for normal growth, fertility, and organ morphology and function. J Clin Invest (2000) 1.53
TAP, a novel T cell-activating protein involved in the stimulation of MHC-restricted T lymphocytes. J Exp Med (1986) 1.49
Neuropathology of degenerative cell death in Caenorhabditis elegans. J Neurosci (1997) 1.48
Collecting duct carcinoma with long survival treated by partial nephrectomy. Int J Urol (2001) 1.48
Palmar reconstruction of the triangular fibrocartilage complex for instability of the distal radioulnar joint: a biomechanical study. J Hand Surg Eur Vol (2012) 1.46
Steroid pulse therapy in lupus cystitis. Intern Med (1996) 1.43
Salvinorin C, a new neoclerodane diterpene from a bioactive fraction of the hallucinogenic Mexican mint Salvia divinorum. Org Lett (2001) 1.43
Efficacy of steroid pulse therapy in lupus cystitis. J Rheumatol (1995) 1.43
Serum cholesterol levels and cognitive function assessed by P300 latencies in an older population living in the community. J Am Geriatr Soc (1997) 1.42
Identification of defects in glycosylphosphatidylinositol anchor biosynthesis in the Thy-1 expression mutants. J Biol Chem (1991) 1.41
Ethnic differences in red blood cell sodium/lithium countertransport and metabolic correlates of hypertension: an international collaborative study. Am J Hypertens (1998) 1.39
Granulocyte colony-stimulating factor induction of improved leukocytopenia with inflammatory flare in a Felty's syndrome patient. Arthritis Rheum (1994) 1.39
Cystic dilatations within the pelvis in patients with ipsilateral renal agenesis or dysplasia. J Urol (1990) 1.39
Interleukin 6 stimulates growth of vascular smooth muscle cells in a PDGF-dependent manner. Am J Physiol (1991) 1.39
Molecular cloning and expression of partial cDNAs and deduced amino acid sequence of a carboxyl-terminal fragment of human apolipoprotein B-100. Proc Natl Acad Sci U S A (1985) 1.35
mago nashi mediates the posterior follicle cell-to-oocyte signal to organize axis formation in Drosophila. Development (1997) 1.34
Linkage of tyrosine kinase activity with transforming ability of the p185neu oncoprotein. Oncogene (1989) 1.34
Proximal extracranial vertebral artery disease in the New England Medical Center Posterior Circulation Registry. Arch Neurol (1998) 1.34
SPT genes: key players in the regulation of transcription, chromatin structure and other cellular processes. J Biochem (2001) 1.34
Molecular cloning and characterization of human AOS1 and UBA2, components of the sentrin-activating enzyme complex. FEBS Lett (1999) 1.33
Regulation of apoptosis and cell cycle progression by MCL1. Differential role of proliferating cell nuclear antigen. J Biol Chem (2000) 1.33
Syringocystadenocarcinoma papilliferum: case report and immunohistochemical comparison with its benign counterpart. J Am Acad Dermatol (2001) 1.33
Epigenetic silencing of AXIN2 in colorectal carcinoma with microsatellite instability. Oncogene (2006) 1.32
Identification and functional expression of four isoforms of ATPase II, the putative aminophospholipid translocase. Effect of isoform variation on the ATPase activity and phospholipid specificity. J Biol Chem (2000) 1.32
Isolation and comparison of two molecular species of the BAL 31 nuclease from Alteromonas espejiana with distinct kinetic properties. J Biol Chem (1983) 1.31
Temporal and spatial patterns of accumulation of the transcript of Myo-inositol-1-phosphate synthase and phytin-containing particles during seed development in rice. Plant Physiol (1999) 1.31
Identification of a novel isopeptidase with dual specificity for ubiquitin- and NEDD8-conjugated proteins. J Biol Chem (2000) 1.30
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer. Br J Cancer (2008) 1.29
Targeting of NEDD8 and its conjugates for proteasomal degradation by NUB1. J Biol Chem (2001) 1.29
Cyclophosphamide-induced ovarian failure and its therapeutic significance in patients with breast cancer. Cancer (1977) 1.29
Characterization of a second member of the sentrin family of ubiquitin-like proteins. J Biol Chem (1998) 1.28
The structure of the human apolipoprotein C-II gene. Electron microscopic analysis of RNA:DNA hybrids, complete nucleotide sequence, and identification of 5' homologous sequences among apolipoprotein genes. J Biol Chem (1985) 1.28
Phase II study of capecitabine plus cisplatin as first-line chemotherapy in advanced gastric cancer. Ann Oncol (2002) 1.27
Tat-SF1 protein associates with RAP30 and human SPT5 proteins. Mol Cell Biol (1999) 1.27
Change in body fat, but not body weight or metabolic correlates of obesity, is related to symptomatic relief of obese patients with knee osteoarthritis after a weight control program. J Rheumatol (1998) 1.26
Biomechanical analysis of rehabilitation in the standing position. Am J Sports Med (1992) 1.25
Inhibition of alpha4 integrin and ICAM-1 markedly attenuate macrophage homing to atherosclerotic plaques in ApoE-deficient mice. Circulation (1998) 1.25